Clinical Research

A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia

Volume: 5 Number: 3 December 15, 2022
EN

A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia

Abstract

This study evaluated cases of spontaneous pneumothorax developing secondary to SARS-CoV-2 pneumonia. Sixteen cases presenting to our hospital due to spontaneous pneumothorax developing secondary to SARS-CoV-2 pneumonia between March 2020 and February 2020 were evaluated retrospectively. Ten patients (62.5%) were men, and six (37.5%) were women, with a mean age of 68 ± 20.3 years (range 18 - 90 years). Pneumothorax was in the right hemithorax in 11 cases (68.75%), in the left hemithorax in two (12.5%), and bilateral in three (17.75%). Pneumothorax developed during active SARS-CoV-2 pneumonia in all 16 cases (100%). No pneumothorax was detected following the healing of SARS-CoV-2 infection. Pneumothorax was observed while patients were not intubated in 15 cases (93.75%), but pneumothorax developed during mechanical ventilation in one case (6.25%). Tube thoracostomy was performed on all patients in treatment. Air leakage from the tube was observed in 14 cases (87.5%). The mean duration of tube thoracostomy was 18.3 ± 20.1 days (range 1 - 81 days). Pneumothorax resolved after treatment in seven cases (43.75%), while mortality occurred in nine (56.25%). Pneumothorax recurred after treatment in one case (6.25%). Pneumothorax is widely seen in the active period or after healing in cases infected with COVID-19. Aggressive treatment is generally required for this clinical manifestation with high mortality.

Keywords

Supporting Institution

yok

References

  1. 1. Onuki T, Ueda S, Yamaoka M, Sekiya Y, Yamada H, Kawakami N, et al. Primary and Secondary Spontaneous Pneumothorax: Prevalence, Clinical Features, and In-Hospital Mortality. Can Respir J. 2017;2017:6014967.
  2. 2. Türkyılmaz A, Erdem AF, Aydın Y, Çinici Ö, Eroğlu A. Treatment of Secondary Spontaneous Pneumothorax: 100-Patient Experience. The Eurasian Journal of Medicine 2007; 39: 97-102. (Turkish).
  3. 3. Elhakim TS, Abdul HS, Pelaez Romero C, Rodriguez-Fuentes Y. Spontaneous pneumomediastinum, pneumothorax and subcutaneous emphysema in COVID-19 pneumonia: a rare case and literature review. BMJ Case Rep. 2020;13:e239489.
  4. 4. Quincho-Lopez A, Quincho-Lopez DL, Hurtado-Medina FD. Case Report: Pneumothorax and Pneumomediastinum as Uncommon Complications of COVID-19 Pneumonia-Literature Review. Am J Trop Med Hyg. 2020;103:1170-1176.
  5. 5. Alhakeem A, Khan MM, Al Soub H, Yousaf Z. Case Report: COVID-19-Associated Bilateral Spontaneous Pneumothorax-A Literature Review. Am J Trop Med Hyg. 2020;103:1162-1165.
  6. 6. Miró Ò, Llorens P, Jiménez S, Piñera P, Burillo-Putze G, Martín A, et al. Frequency, Risk Factors, Clinical Characteristics, and Outcomes of Spontaneous Pneumothorax in Patients With Coronavirus Disease 2019: A Case-Control, Emergency Medicine-Based Multicenter Study. Chest. 2021;159:1241-1255.
  7. 7. Rafiee MJ, Babaki Fard F, Samimi K, Rasti H, Pressacco J. Spontaneous pneumothorax and pneumomediastinum as a rare complication of COVID-19 pneumonia: Report of 6 cases. Radiol Case Rep. 2021;16:687-692.
  8. 8. Akçay Ş, Özlü T, Yılmaz A. Radiological approaches to COVID-19 pneumonia. Turk J Med Sci. 2020;50:604-610.

Details

Primary Language

English

Subjects

Microbiology

Journal Section

Clinical Research

Publication Date

December 15, 2022

Submission Date

May 13, 2022

Acceptance Date

August 8, 2022

Published in Issue

Year 2022 Volume: 5 Number: 3

APA
Taş, N., Naldan, M., Öner, F., Naldan, H., & Aydin, Y. (2022). A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia. International Journal of Life Sciences and Biotechnology, 5(3), 562-571. https://doi.org/10.38001/ijlsb.1116153
AMA
1.Taş N, Naldan M, Öner F, Naldan H, Aydin Y. A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia. Int. J. Life Sci. Biotechnol. 2022;5(3):562-571. doi:10.38001/ijlsb.1116153
Chicago
Taş, Nurmuhammet, Muhammet Naldan, Fatih Öner, Hülya Naldan, and Yener Aydin. 2022. “A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia”. International Journal of Life Sciences and Biotechnology 5 (3): 562-71. https://doi.org/10.38001/ijlsb.1116153.
EndNote
Taş N, Naldan M, Öner F, Naldan H, Aydin Y (December 1, 2022) A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia. International Journal of Life Sciences and Biotechnology 5 3 562–571.
IEEE
[1]N. Taş, M. Naldan, F. Öner, H. Naldan, and Y. Aydin, “A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia”, Int. J. Life Sci. Biotechnol., vol. 5, no. 3, pp. 562–571, Dec. 2022, doi: 10.38001/ijlsb.1116153.
ISNAD
Taş, Nurmuhammet - Naldan, Muhammet - Öner, Fatih - Naldan, Hülya - Aydin, Yener. “A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia”. International Journal of Life Sciences and Biotechnology 5/3 (December 1, 2022): 562-571. https://doi.org/10.38001/ijlsb.1116153.
JAMA
1.Taş N, Naldan M, Öner F, Naldan H, Aydin Y. A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia. Int. J. Life Sci. Biotechnol. 2022;5:562–571.
MLA
Taş, Nurmuhammet, et al. “A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia”. International Journal of Life Sciences and Biotechnology, vol. 5, no. 3, Dec. 2022, pp. 562-71, doi:10.38001/ijlsb.1116153.
Vancouver
1.Nurmuhammet Taş, Muhammet Naldan, Fatih Öner, Hülya Naldan, Yener Aydin. A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia. Int. J. Life Sci. Biotechnol. 2022 Dec. 1;5(3):562-71. doi:10.38001/ijlsb.1116153



Follow us on social networks  19277 19276 20153  22366